Neil Warma K.'s most recent trade in ProMIS Neurosciences Inc. was a trade of 160,000 Option (right to buy) done . Disclosure was reported to the exchange on May 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc | Neil K. Warma | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 160,000 | 160,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Neil K. Warma | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.13 per share. | 03 Feb 2026 | 6,183 | 6,183 | - | 12.1 | 75,000 | Common Shares |
| ProMIS Neurosciences Inc | Neil K. Warma | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 6,183 | 6,183 | - | - | Warrants to purchase Common Shares | |
| ProMIS Neurosciences Inc | Neil K. Warma | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2025 | 600,000 | 600,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Neil K. Warma | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 1,144,122 | 1,352,455 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Neil K. Warma | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 490,338 | 1,842,739 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Neil Warma K. | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 200,000 | 208,333 | - | - | Option (right to buy) |